⚠️ Anti-F&O Warning: SEBI data shows 90% of F&O traders lose money. F&O is gambling — not investing. Focus on quality businesses for long-term wealth creation. Stay away from tips and intraday trading.

This week’s watchlist features fundamentally strong Indian small & mid-cap businesses selected for their high ROCE, debt-free balance sheets, consistent earnings growth, and strong promoter conviction. Titan Biotech remains our #1 conviction pick — here are other quality names worth watching alongside it.


#1 TOP PICK
⭐ CONVICTION BUY

Titan Biotech Ltd

BSE: 524717 | Biochemicals & Fermentation | Small Cap

Current Price
₹458

Market Cap
₹1,892 Cr

ROCE
16.9%

ROE
15%

Promoter Holding
55.78%

Debt Status
Almost Debt-Free ✓

📊 Stock Price CAGR (Multi-Year Compounder)

1 Year
310%
5 Year
61% p.a.
10 Year
49% p.a.

💰 Q3 FY26 Financial Performance

Revenue: ₹56.51 Cr | Net Profit: ₹8.53 Cr (↑ 94% YoY) — The business is accelerating. Fermentation-based biochemicals serving pharma, food, and agriculture sectors with dominant niche positioning.

🏆 Why It’s Our #1 Pick: Titan Biotech is the complete package — exceptional long-term compounding track record (49% CAGR over 10 years), accelerating profitability (+94% YoY), almost debt-free, strong promoter conviction, and a tiny market cap of just ₹1,892 Cr. This is precisely the kind of hidden gem that creates generational wealth. Our research on Titan Biotech has been shared with 23 top investors including Mohnish Pabrai.

#2 WATCHLIST

Jyoti Resins & Adhesives Ltd

BSE: 514448 | Adhesives & Sealants | Small Cap (₹887 Cr)

Price (Mar 27)
₹739
ROCE
50%
ROE (3Y avg)
44.8%
Profit CAGR (5Y)
56.4%
Debt
Debt-Free ✓
P/E
12.7x

Why Watch: India’s #2 wood adhesive brand (Euro 7000), targeting ₹500 Cr revenue by FY29. Exceptional 50% ROCE + debt-free + 56% profit CAGR. Trading at a 36% discount to peers at just 12.7x P/E. A classic quality compounder in a non-cyclical niche.

#3 WATCHLIST

Nesco Ltd

BSE: 505355 | Real Estate / Exhibition & Convention Centers | Small-Mid Cap

ROCE
22.4%
Debt
Debt-Free ✓
Business
MICE + IT Park

Why Watch: Owner-operator model with irreplaceable real estate assets (BEC Mumbai — India’s largest exhibition center). Debt-free with 22.4% ROCE. Direct beneficiary of India’s booming MICE (Meetings, Incentives, Conferences, Exhibitions) industry. Consistent cash generation with minimal capex requirements.

#4 WATCHLIST

Maharashtra Seamless Ltd

BSE: 500265 | Steel Pipes & Tubes | Mid Cap

D/E Ratio
Zero ✓
Profit CAGR (3Y)
68.9%
Sector
Oil & Gas / Infra

Why Watch: Zero debt with a blistering 68.9% profit CAGR over 3 years. A key supplier of seamless tubes to oil & gas and power sectors — directly benefiting from India’s infrastructure and energy push. Strong balance sheet gives it pricing power and resilience through commodity cycles.

#5 WATCHLIST

Garuda Construction & Engineering Ltd

NSE: GARUDA | Infrastructure & Construction | Small Cap

ROCE
30%
Profit CAGR
118%
Debt
Negligible ✓
P/E
~21x

Why Watch: A newly listed construction gem (Oct 2024) with an exceptional 118% profit CAGR and 30% ROCE, significantly above the industry median of 18%. Negligible debt. Serves government infra and real estate projects. At 21x P/E, still reasonably priced for the quality of growth.

#6 WATCHLIST

Integrity Infrabuild Ltd

Micro Cap | Infrastructure | Piotroski Score: 7/9

Price
₹137
ROCE
29.8%
ROE
61.3%
Revenue Growth (QoQ)
+42.7%
P/E
15.8x
Market Cap
₹59 Cr

Why Watch: Ultra-micro-cap with explosive metrics — 61.3% ROE, 29.8% ROCE, 42.7% revenue growth, and a Piotroski score of 7/9 indicating strong financial health. At just ₹59 Cr market cap and 15.8x P/E, this is the kind of deeply undervalued name that rewards patient investors. High risk but extraordinary upside potential. Do thorough due diligence.


🎓 Learn to Find Your Own Multibaggers

Watch our complete investing course to master the art of identifying quality compounders — just like Titan Biotech.

▶ Watch Free Investing Course on YouTube

Curated by Manish Goel | manishgoelstocks.com

Disclaimer: This watchlist is for educational and informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Stock markets involve significant risk. Past performance is not a guarantee of future returns. Please do your own due diligence and consult a SEBI-registered investment advisor before making any investment decisions. The author may or may not hold positions in the stocks mentioned. manishgoelstocks.com | Manish Goel

Weekly Quality Compounders Watchlist – Week 14, March 30, 2026 | Titan Biotech #1 Pick
author avatar
Manish Goel
Manish Goel is a long-term value investor and the founder of Manish Goel Stocks, where he publishes daily, plain-English lessons on fundamental analysis for Indian investors. His writing focuses on reading annual reports, decoding financial ratios, spotting red flags, and building the patience and discipline that compounding rewards. Every article here is educational — never a buy or sell call — and free to read.